Brief Title
Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Official Title
A Multi-center Prospective Cohort Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Brief Summary
This clinical study aims to investigate the anti-HPA antibodies caused neonatal alloimmune
thrombocytopenia in Chinese pregnant women. The survey and data collect will help form an
appropriate clinical screening procedure
Study Type
Observational
Primary Outcome
The positive rate of anti-HPA antibody
Secondary Outcome
Antigenic specificity of anti-HPA antibodies
Condition
Neonatal Alloimmune Thrombocytopenia
Intervention
Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
Study Arms / Comparison Groups
Control Group
Description: Pregnant women with anti-HPA antibody negative from the same hospital, the same race, and the same gravidity and parity, who are admitted at the same time.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
55497
Start Date
January 2017
Primary Completion Date
December 2019
Eligibility Criteria
Inclusion Criteria:
- 12-28 weeks pregnant Chinese women
- between Jan 1, 2017 and Dec 31, 2018
Exclusion Criteria:
- Not willing to participate in this study
- Plan to terminate pregnancy early
Gender
Female
Ages
18 Years - 50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Contacts
, 0118615178936688, [email protected]
Administrative Informations
NCT ID
NCT02934906
Organization ID
V2.0(20160720)
Responsible Party
Principal Investigator
Study Sponsor
Xinqiao Hospital of Chongqing
Collaborators
Air Force Military Medical University, China
Study Sponsor
, ,
Verification Date
October 2016